The Story Behind the Cover Picture
Cat “Cream” and 10-Year birthday of HepatoBiliary Surgery and Nutrition (HBSN)
HepatoBiliary Surgery and Nutrition
2022;
11
(6)
:793-794
.
(01 December 2022)
Original Article
Combined non-alcoholic fatty liver disease and type 2 diabetes in severely obese patients—medium term effects of sleeve gastrectomy versus Roux-en-Y-gastric bypass on disease markers
HepatoBiliary Surgery and Nutrition
2022;
11
(6)
:795-807
.
(01 December 2022)
Our retrospective pair-matched analysis suggests that bariatric surgery with Sleeve Gastrectomy may be preferable to Roux-Y-Gastric Bypass for obese patients with NAFLD and Type 2 Diabetes Mellitus based on the medium-term rates of remission of markers of these co-morbidities.
Propensity score matching study of 325 patients with spontaneous rupture of hepatocellular carcinoma
HepatoBiliary Surgery and Nutrition
2022;
11
(6)
:808-821
.
(01 December 2022)
Ruptured hepatocellular carcinoma (RHCC) is a serious bleeding complication with a high mortality. Emergency trans-arterial embolization (TAE) plus two-stage hepatectomy might be the optimal treatment for patients with RHCC, which prognosis were no significant difference from that of non-ruptured HCC patients who undergoing hepatectomy.
International assessment and validation of the prognostic role of lymph node ratio in patients with resected pancreatic head ductal adenocarcinoma
HepatoBiliary Surgery and Nutrition
2022;
11
(6)
:822-833
.
(01 December 2022)
This international multicenter cross-sectional study (n=1327) demonstrated that lymph node ratio (LNR) was a strong overall survival (OS) predictor in the entire cohort of patients with resected pancreatic head ductal adenocarcinoma and in patients with lymph node involvement. Furthermore, patients with LNR<0.225 had better OS than patients with LNR≥0.225.
Serum metabolic effects of corn oligopeptides with 7-day supplementation on early post-surgery primary liver cancer patients: a double-blind randomized controlled trial
HepatoBiliary Surgery and Nutrition
2022;
11
(6)
:834-847
.
(01 December 2022)
Characteristics and outcomes of hepatocellular carcinoma patients with macrovascular invasion following surgical resection: a meta-analysis of 40 studies and 8,218 patients
HepatoBiliary Surgery and Nutrition
2022;
11
(6)
:848-860
.
(01 December 2022)
In this meta-analysis, we determined that hepatocellular carcinoma patients with macrovascular invasion who underwent resection had a poor overall survival. However, among patients with 2nd order portal vein tumor thrombus, median survival was 20 months, suggesting that surgical resection may be considered in selected patients.
Review Article
Systemic review of the robustness of randomized controlled trials for the treatment of cholangiocarcinoma in three domains: survival-inferred fragility index, restricted mean survival time, and the spin effect
HepatoBiliary Surgery and Nutrition
2022;
11
(6)
:861-869
.
(01 December 2022)
Editorial from the ACHBPT
Advanced nonmetastatic hepatocellular carcinoma: curative surgery may be an option
HepatoBiliary Surgery and Nutrition
2022;
11
(6)
:870-872
.
(01 December 2022)
Editorial
Peri-hospital care: time to have a system for arranging patient care before and after hospitalization
HepatoBiliary Surgery and Nutrition
2022;
11
(6)
:873-875
.
(01 December 2022)
Atezolizumab plus bevacizumab for patients with Child-Pugh-B in hepatocellular carcinoma
HepatoBiliary Surgery and Nutrition
2022;
11
(6)
:876-878
.
(01 December 2022)
High volume transplant experience is beneficial but not mandatory for the performance of complex liver resections
HepatoBiliary Surgery and Nutrition
2022;
11
(6)
:879-881
.
(01 December 2022)
Precision oncology and molecular therapies for hepatocellular carcinoma
HepatoBiliary Surgery and Nutrition
2022;
11
(6)
:882-885
.
(01 December 2022)
Can metabolomic signature foster precision medicine approaches in nonalcoholic fatty liver disease arena?
HepatoBiliary Surgery and Nutrition
2022;
11
(6)
:886-888
.
(01 December 2022)
In search of a roadmap towards improving care of patients with cirrhosis and ascites, could a platform trial design transform clinical research?
HepatoBiliary Surgery and Nutrition
2022;
11
(6)
:889-892
.
(01 December 2022)
Surgical Infection Society guidelines on antibiotic use in gallstone surgery: high time we crack down on prophylactic antibiotics
HepatoBiliary Surgery and Nutrition
2022;
11
(6)
:893-895
.
(01 December 2022)
Highlights of constructing liver-relevant in vitro models with 3D bioprinting
HepatoBiliary Surgery and Nutrition
2022;
11
(6)
:896-898
.
(01 December 2022)
Evolution of systemic therapy for advanced-stage hepatocellular carcinoma
HepatoBiliary Surgery and Nutrition
2022;
11
(6)
:899-902
.
(01 December 2022)
Management of severe acute pancreatitis: all hands to the pump
HepatoBiliary Surgery and Nutrition
2022;
11
(6)
:903-905
.
(01 December 2022)
Perioperative management of patients with liver cancer complicated with sarcopenia
HepatoBiliary Surgery and Nutrition
2022;
11
(6)
:906-908
.
(01 December 2022)
Cystic liver lesions: from diagnosis to recognition of complications and when to treat
HepatoBiliary Surgery and Nutrition
2022;
11
(6)
:909-912
.
(01 December 2022)
New guidelines for the treatment of severe acute pancreatitis
HepatoBiliary Surgery and Nutrition
2022;
11
(6)
:913-916
.
(01 December 2022)
Advances in 3D bioprinting technology for liver regeneration
HepatoBiliary Surgery and Nutrition
2022;
11
(6)
:917-919
.
(01 December 2022)
Commentary
Non-invasive tests for fibrosis detection: still in search for the best way
HepatoBiliary Surgery and Nutrition
2022;
11
(6)
:920-923
.
(01 December 2022)
Hepatic metastases in ovarian cancer
HepatoBiliary Surgery and Nutrition
2022;
11
(6)
:924-926
.
(01 December 2022)
Atezolizumab plus bevacizumab and tremelimumab plus durvalumab: how should we choose these two immunotherapy regimens for advanced hepatocellular carcinoma?
HepatoBiliary Surgery and Nutrition
2022;
11
(6)
:927-930
.
(01 December 2022)
Approach to systemic therapy in advanced hepatocellular carcinoma
HepatoBiliary Surgery and Nutrition
2022;
11
(6)
:931-934
.
(01 December 2022)
Viewpoint
Endoscopic ultrasound (EUS) or endoscopic retrograde cholangiopancreatography (ERCP): is that the question?
HepatoBiliary Surgery and Nutrition
2022;
11
(6)
:935-937
.
(01 December 2022)
Letter to the Editor
Intrahepatic portal vein variant: a single dilated intrahepatic portal vein coursing to the umbilical fissure without second-order branches
HepatoBiliary Surgery and Nutrition
2022;
11
(6)
:938-941
.
(01 December 2022)
Spontaneous rupture of hepatocellular carcinoma trans-arterial embolization or hepatectomy?
HepatoBiliary Surgery and Nutrition
2022;
11
(6)
:942-943
.
(01 December 2022)
